Letter/Communication
Raising the Hemostatic Bar in Hemophilia A: The Promise of Mim8
NEJM clinician (Online)
05/20/2026
DOI: 10.1056/CLINjwNA60116
Abstract
Clinical Takeaway Mim8, a bispecific antibody similar to emicizumab, offers prophylactic efficacy with convenient subcutaneous dosing.
Details
- Title: Subtitle
- Raising the Hemostatic Bar in Hemophilia A: The Promise of Mim8
- Creators
- Anjali A Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM clinician (Online)
- DOI
- 10.1056/CLINjwNA60116
- ISSN
- 3069-096X
- eISSN
- 3067-1876
- Publisher
- Massachusetts Medical Society
- Language
- English
- Date published
- 05/20/2026
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9985218398002771
Metrics
1 Record Views